COLL Collegium Pharmaceutical


From Benzinga Pro
5 Value Stocks To Watch In The Healthcare Sector
3 Jan 22
What Defines a Value Stock?
Needham Maintains Buy on Collegium Pharmaceutical, Raises Price Target to $28
15 Nov 21
News, Price Target, Analyst Ratings
Needham analyst Serge Belanger maintains Collegium Pharmaceutical (NASDAQ:COLL) with a Buy and raises the price target from $26 to $28.
A Look Into Healthcare Sector Value Stocks
8 Nov 21
What is a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.
Collegium Pharmaceutical Q3 EPS $0.22 Down From $0.32 YoY
4 Nov 21
Earnings, News
Collegium Pharmaceutical (NASDAQ:COLL) reported quarterly earnings of $0.22 per share. This is a 31.25 percent decrease over earnings of $0.32 per share from the same period last year.
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
4 Nov 21
Biotech, Earnings, News, Penny Stocks, Guidance, Offerings, Small Cap, FDA, IPOs, General
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK
Earnings Scheduled For November 4, 2021
4 Nov 21
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • DISH Network (NASDAQ:DISH) is likely to report quarterly earnings at $0.91 per share on revenue of $4.45 billion.
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
31 Oct 21
Biotech, Earnings, News, Penny Stocks, Small Cap, FDA, IPOs, Top Stories
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected.